T hymus is the primary lymphatic organ responsible for producing T cells. In thymus, bone marrow (BM)-derived progenitors undergo a well-orchestrated developmental program and a series of selection processes to generate mature naïve T cells. [1] [2] [3] [4] The continuous T-cell production from thymus is essential in maintaining T-cell homeostasis and optimal T-cell function in the periphery. [5] [6] [7] However, thymic involution can be induced by a couple of factors, such as aging, 8 infections, 9 pregnancy, 10 and some clinical preparative regimens. 11, 12 Thymic involution disrupts T-cell development, impairs immune responses, and increases risks of infections. [13] [14] [15] Therefore, understanding how thymopoiesis is regulated is of great significance for halting thymic involution, accelerating thymic regeneration, and improving the immune functions in the elderly and particular patients.
SR-BI (Scavenger receptor class B type 1) is a transmembrane protein most abundantly expressed in the liver and steroidogenic tissues. As the first identified physiological HDL (high-density lipoprotein) receptor, [16] [17] [18] SR-BI plays essential roles in regulating HDL metabolism. 16, [19] [20] [21] [22] In mice, SR-BI deficiency caused a 2-fold increase in plasma cholesterol levels, which was characterized by the accumulation of cholesterol in HDL particles, 18, 23 and increased susceptibility to atherosclerosis. [24] [25] [26] In humans, mutations of SR-BI also led to elevated plasma HDL concentrations, alternated cholesterol metabolism and increased risk of cardiovascular disease. [27] [28] [29] Emerging evidence indicated that SR-BI was able to exert multiple functions in addition to modulating HDL metabolism. For instance, SR-BI had been shown to control glucocorticoid production, 30, 31 activate endothelial nitric oxide synthase in endothelial cells, [32] [33] [34] [35] induce apoptosis, 36 ,37 modulate erythrocyte development 38, 39 and platelet function, [40] [41] [42] [43] and protect against LPS-induced endotoxemia or polymicrobial bacteria-induced sepsis. 30, [44] [45] [46] [47] Our group previously reported that SR-BI also played a role in modulating adaptive immunity. In mice, SR-BI deficiency resulted in impaired lymphocyte homeostasis, which was characterized by lymphocyte expansion, hyperactivation, and +/− mice, and the SR-BI +/+ littermates were used as controls. For BM transplantation (BMT) experiments and long-term homing assay, SR-BI +/− mice were backcrossed with C57BL/6J mice for >10 generations to generate SR-BI −/− mice and SR-BI +/+ controls in C57BL/6J background. Male SR-BI −/− mice and female Rag-1 −/− mice were cross-bred to generate double heterozygous offspring, which were subsequently intercrossed to generate SR-BI +/− Rag-1 −/− breeders. The SR-BI +/− Rag-1 −/− breeders were used to generate SR-BI −/− Rag-1 −/− and SR-BI +/+ Rag-1 −/− controls. SR-BI −/− LDLR −/− mice were generated with the same strategy. All the mice were fed a standard laboratory diet (Harlan Tekland 2018) if not otherwise stated. The high-fat diet contains 1.25% cholesterol and 0.5% sodium cholate (Harlan Tekland 88051). Probucol (Sigma) was dissolved in ethanol at 55°C before being sprayed on normal diet at 0.2% by weight. Then the probucol-added diet was dried for 1 week before use. Animal care and experiments were approved by the Institutional Animal Care and Use Committee of the University of Kentucky.
Antibodies
Fluorescein isothiocyanate-conjugated anti-CD8α (53.67), TCR-β (T-cell receptor; H57), TCR-γ/δ (GL3), CD3ε (17A2), CD8β (53-5.8) , CD19 (6D5), B220 (RA3-6B2),CD11b (M1/70), CD11c (n148), Ter119, GR-1 (glucocorticoid receptor-1; RB6-8C5), NK1.1 (PK136), CD4 (GK1.5), CD2 (RM2.5); PE-conjugated CD4 (GK1.5), CD69 (H1.2F3), cKit (2B8); PE-cy5-conjugated CD44 (IM7); APC (allophycocyanin)-conjugated CD4 (GK1.5), CD25 (PL61), CD135 (A2F10); PE-cy7-conjugated CD62L (MEL-14), CD45.1 (A20), IL (interleukin)-7Rα (A7R34); and APC-cy7-conjugated CD45.2 (104), Sca-1 (D7) were from BD Biosciences or Biolegend.
Fluorescence-Activated Cell Sorting Analysis
Single-cell suspensions from the thymus, BM and peripheral lymph nodes (LNs) were obtained by disrupting tissues through 100 μm cell strainers. Single-cell suspensions of splenocytes were prepared using Stomacher 80 (Seward) and incubated with ACK lysis buffer (0.15 mol/L NH 4 Cl, 10 mmol/L KHCO 3 , 0.1 mmol/L EDTA-2Na, and pH=7.4) to deplete erythrocytes. Blood cell suspensions were obtained by incubating anti-clotted blood with ACK lysis buffer to remove erythrocytes. Cells were then counted, stained with antibodies following the manufacturer's instructions and analyzed with FACSCalibur or LSRII (BD Biosciences). The data were analyzed with FlowJo software (Treestar).
Quantitation of T-Cell Receptor Excision Circles

CD4
+ and CD8 + splenocytes were sorted with an iCyt Synergy sorter system (Sony). Cell lysates were prepared by incubation with proteinase K (QIAGEN) at 55°C for 1 hour, followed by inactivation at 95°C for 15 minutes. The lysate from 50 000 cells/5 μL was added to a real-time quantitative polymerase chain reaction. The primers and reaction program were described formerly. 49 The standard curves for murine T-cell receptor excision circles (TRECs) were generated by using a standard mouse TRECs plasmid, which was a generous gift from Dr Gregory D. Sempowski 
In Vivo BrdU Proliferation Assay
Mice were given 2 IP injections (spaced 24 hours apart) of 1 mg BrdU in 200 μL sterile PBS. Forty-eight hours after the first injection, splenocytes or thymocytes from mice were first stained with surface antibodies, followed by BrdU incorporation detection using the APC BrdU flow kit following the manufacturer's protocol (BD Biosciences).
TUNEL Staining and Filipin Staining
For TUNEL (terminal deoxynucleotidyl transferase dUTP nick-end labeling) staining, thymocytes were first stained with surface antibodies, followed by fixation and permeabilization using a cell Fixation/ Permeabilization kit (BD Biosciences). The fixed cells were then labeled with TUNEL following the manufacturer's instructions (Roche) or incubated with incubated with 100 μL 100 μg/mL filipin (Sigma) in 1× BD Perm/Wash buffer for 1 hour at 37°C, before being analyzed with flow cytometer.
In Vitro T-Cell Activation
Splenocytes or LN cells from mice were plated at indicated concentrations in RPMI (Roswell Park Memorial Institute) 1640 medium supplemented with 10% FBS, 5 mmol/L L-glutamine (Gibco), 100 units/mL penicillin, 100 μg/mL streptomycin, and 50 μmol/L 2-mercaptoethanol. For anti-CD3 stimulation, the plates were incubated with 100 μL anti-CD3 (eBioscience) in PBS at indicated concentrations overnight and washed twice with 100 μL PBS before use. For proliferation assay, 5 μg/mL pre-bound anti-CD3 were used to stimulate T cells and 10 μmol/L BrdU was added to track newborn cells. For activation assay, cells were stimulated with indicated concentrations of pre-bound anti-CD3 and soluble anti-CD28 (eBioscience).
Plasma Cholesterol Determination
Fresh anticoagulated blood was drawn by tail bleeding or from abdominal aorta from mice and used to determine plasma cholesterol concentrations. 
BM Transplantation
The recipient mice were first maintained on antibiotic water (sulfatrim, 4 µg/mL) for 6 days and then irradiated with 2 doses of 400 Rads from a cesium source that was delivered within 3 to 4 hours. BM cells (BMCs) were obtained from the femurs of donor mice and were injected via tail vein into irradiated recipient mice (5×10 6 cells per mouse). Mice were maintained on antibiotic water for 4 weeks after transplantation and then changed to regular water for 2 weeks before analysis.
BM Progenitor Homing Assay
For the short-term homing assay, BMCs from SR-BI +/+ mice were first labeled with carboxyfluorescein succinimidyl ester (CFSE; Molecular Probes) following manufacturer's instructions and then injected to nonirradiated mice via tail vein at 20 million cells per mouse in 100 μL PBS. Two days later, mice were euthanized and CFSE + cells were analyzed through fluorescence-activated cell sorting. For long-term homing assay, BMCs from CD45.1 + mice were injected to nonirradiated mice via tail vein at 20 million cells per mouse. Two weeks later, mice were sacrificed and analyzed.
Sublethal Irradiation
Mice (8-10 weeks) were irradiated with a single dose of 450 Rads from a cesium source. Then the irradiated mice were maintained on regular water and normal diet for 4, 7, or 14 before analysis.
Western Blot
Thymi from 5-week mice were first lysed with cell lysis buffer (cell signaling) in the presence of proteinase inhibitor (Sigma). The protein concentration in the supernatant was determined by Lowry protein assay 50 with a commercial kit (Biorad). Then, 100 μg (by protein) cell lysate was loaded and resolved in a 12.5% polyacrylamide gel. After the gel electrophoresis, the protein in the gel was electrically transferred to a polyvinylidene fluoride membrane, before being blotted with anti-caspase 1 (4B4, a gift from Dr Vishva Dixit, Genentech) and anti-β-tubulin (E7-c, developmental studies).
Adrenal Transplantation
The procedure of adrenal transplantation was previously described. 51, 52 Adrenal glands were harvested from 9-day SR-BI +/+ or SR-BI −/− donors. The SR-BI +/+ recipient mouse (10-12 weeks) was adrenalectomized bilaterally, and 1 donor adrenal gland was put under the right kidney capsule through a slit made. After the surgery, the recipient was maintained on water containing 0.9% NaCl.
Statistical Analyses
Data were presented as mean±SEM or mean±SD. Significance in experiments was determined by a 2-tailed Student t test. One-way ANOVA test was used if the comparison involves >2 groups, followed by post hoc analysis using the Tukey range test. Means were considered significantly different at P<0.05.
Results
SR-BI Deficiency Causes Reduced Thymus Size
To explore the role of SR-BI in T-cell development, we examined thymus sizes of SR-BI-null mice at different ages. Though the age-related decrease in thymic size was observed in both groups, after puberty, SR-BI −/− mice displayed significantly lower thymus weight than age-matched SR-BI +/+ controls until 32 weeks ( Figure 1A and 1B). Older SR-BI −/− mice (>32 weeks) did not show smaller thymus weight than SR-BI +/+ controls, as the thymus weight in both groups had declined to a low level. In line with the reduced thymus weight, SR-BI −/− mice showed markedly decreased thymocyte number compared with age-matched controls ( Figure 1C and 1D). Notably, the decrease in thymic cellularity because of SR-BI deficiency was also observed in mice >32 weeks. These data clearly indicated that SR-BI was required for maintaining normal thymus size. The effect of SR-BI deficiency on thymus size was not sex-dependent, as both male and female SR-BI −/− mice displayed reductions in thymus weight and thymic cellularity ( Figure I in the online-only Data Supplement). SR-BI deficiency did not affect thymus size before puberty, as 1-week-old SR-BI −/− mice showed 
SR-BI Deficiency Causes Decreased Thymic Output and Impaired Peripheral T-Cell Homeostasis
Next, we evaluated if SR-BI deficiency influenced T cell export from thymus. To this purpose, we isolated CD4 + and CD8 + splenocytes from mice and analyzed TRECs, which were generated during TCR rearrangements and nicely correlated with T-cell production. 49 As expected, in both CD4 + and CD8 + splenocytes, SR-BI −/− mice exhibited lower frequencies ( 
SR-BI Deficiency Causes a Decrease in Earliest Thymic Progenitors but Did Not Block the Downstream T-Cell Development Program
To figure out how T-cell development was influenced by SR-BI deficiency, we first stained thymocytes with CD4 and CD8, dividing them to 4 major subtypes: double negative (DN), double positive, CD4 single positive (SP), and CD8 SP thymocytes. Consistent with our former observations, 48 SR-BI −/− mice did not display any change in the thymic CD4/CD8 profile, but only caused corresponding reductions in the numbers of each population ( Figure 3A ; Figure − population ( Figure 3C ; Figure VII in the online-only Data Supplement) and in total thymocytes ( Figure 3D ) were reduced by 50% and 40%, respectively, leading to a 65% decrease in the number of ETPs in SR-BI −/− thymi ( Figure 3E ). These observations demonstrated that SR-BI deficiency caused a dramatic decrease in ETPs.
SR-BI Deficiency Impairs Progenitor Thymic Homing
Because the ETPs are the most primitive population in thymocytes, we asked if SR-BI deficiency affected T-cell development upstream of ETPs. Because of a lack of self-renewal progenitors in thymus, long-term thymopoiesis depends on continuous settlement of BM progenitors to thymus. Figure 3G ). These observations revealed that absence of SR-BI in the recipients impaired the entry of BM progenitors to the thymus.
To determine how the reduced BMC entry into thymus in SR-BI −/− mice affected the downstream T-cell numbers, we injected 20 million CD45.1 + BMCs into nonirradiated mice and analyzed the donor-derived thymocytes 2 weeks later. As expected, the percentage ( Figure 3H ; Figure IXA in the online-only Data Supplement) and number ( Figure 3I ) of CD45.1 + thymocytes were both significantly lower in SR-BI −/− mice, indicating that the contribution of circulating BM progenitors to thymopoiesis was reduced by SR-BI deficiency. Interestingly, the CD45.1 + cells in SR-BI −/− thymi showed a similar CD4/CD8 profile with those in SR-BI +/+ thymi ( Figure 3J ; Figure IXB in the online-only Data Supplement), which confirmed that the downstream development of settled progenitors was intact in the deficient mice. These findings supported the conclusion that SR-BI deficiency impaired thymopoiesis through affecting the thymic homing process of BM progenitors.
SR-BI Deficiency Causes Impaired Thymic Recovery After Irradiation
Thymic regeneration in early stages depends on intrathymic precursors 59 and in long-term requires the homing of BM progenitors. 60 As SR-BI deficiency caused a decrease in ETPs and impaired progenitor thymic homing, we hypothesized that SR-BI deficiency led to delayed thymic regeneration after thymocyte depletion. To test this hypothesis, we induced thymocyte depletion in mice by sublethal irradiation and evaluated the subsequent thymic recovery. Four days after irradiation, SR-BI +/+ and SR-BI −/− mice exhibited equally low levels of thymocyte numbers (Figure 4A ), indicating that SR-BI deficiency did not influence irradiation-induced thymocyte death. Nevertheless, from day 4 to day 7 after irradiation, thymic cellularity of SR-BI +/+ mice was increased by 8.4-fold, whereas that of SR-BI −/− mice was only elevated by 3.1-fold ( Figure 4A ), indicating that thymic recovery was slower in the absence of SR-BI. At day 14 after irradiation, there was still a trend of lower thymocyte counts in SR-BI −/− mice (32% lower than those of SR-BI +/+ mice; Figure 4A ). These results revealed that SR-BI deficiency caused impaired thymic recovery after irradiation. Of note, despite the delayed thymic recovery, SR-BI −/− mice also showed a comparable CD4/CD8 profile with SR-BI +/+ mice postirradiation ( Figure 4B ). To evaluate if the delayed thymic regeneration resulted from the impaired progenitor thymic homing because of SR-BI deficiency, we transplanted CD45. + and CD8 + cells were reduced by 34% and 44%, respectively ( Figure 4G ), indicating that the repopulation of peripheral T cells was also halted by SR-BI deficiency. Altogether, these data elucidated that SR-BI deficiency delayed thymic regeneration by impairing progenitor thymic homing.
Hematopoietic SR-BI deficiency Is Not Responsible for Impaired T-Cell Development
The progenitor homing assay and BMT experiments also indicated that the nonhematopoietic SR-BI deficiency was responsible for the impaired T-cell development. However, whether or not hematopoietic SR-BI deficiency also contributed to the defects in T-cell development remained unknown. To answer this question, we mixed CD45. 
SR-BI Deficiency-Induced Hypercholesterolemia Is Not Responsible for Impaired T-Cell Development
SR-BI deficiency caused hypercholesterolemia with abnormally large HDL particles and accumulation of free cholesterol on HDL, which had been shown responsible for several secondary abnormalities. 38, 39, [61] [62] [63] To test if the SR-BI deficiency-induced hypercholesterolemia was responsible for the impairment in T-cell development, we first examined the plasma cholesterol level in 5-week-old SR-BI −/− mice and found that the impaired T-cell development was associated with a >2-fold elevation in plasma cholesterol concentration ( Figure 
Adrenal SR-BI Deficiency Is Responsible for Impaired T-Cell Development
In addition to hypercholesterolemia, another well-documented defect of SR-BI-deficient mice was the impaired adrenal function. SR-BI-mediated cholesterol uptake is an essential pathway to supply cholesterol to adrenal glands for steroid synthesis. 67 Lack of SR-BI in the adrenal gland caused a deficiency in inducible glucocorticoid production in response to stress, 30, 31, 45, 68 which was responsible for the elevated endotoxic and septic animal death, 30, 68 and impaired thymocyte apoptosis during sepsis. 63 Considering the critical role of glucocorticoid/ GR in T-cell development, we assessed if adrenal SR-BI plays a role in modulating thymopoiesis. We first conducted adrenalectomy on SR-BI +/+ and SR-BI −/− mice. As shown in Figure  XVI in the online-only Data Supplement, there was no significant difference in thymocyte or ETP number between adrenalectomized SR-BI −/− mice and wild-type controls. Next, we generated adrenal-specific SR-BI-deficient mice by transplanting an adrenal gland from SR-BI −/− mice to adrenalectomized SR-BI +/+ mice. Six weeks after transplantation, the recipients receiving SR-BI +/+ adrenal gland (ADR-T SR-BI +/+ mice) displayed a robust inducible glucocorticoid secretion under cecal ligation and puncture, whereas those receiving SR-BI −/− adrenal gland (ADR-T SR-BI −/− mice) totally lacked inducible glucocorticoid production. 68 Interestingly, ADR-T SR-BI −/− mice displayed significantly lower thymus weight ( Figure 5A ) and thymic cellularity ( Figure 5B ) than ADR-T SR-BI +/+ mice, indicating the absence of SR-BI in adrenal gland was responsible for the reduction in thymus size. Similar to SR-BI −/− mice, ADR-T SR-BI −/− mice displayed normal CD4/CD8 profile ( Figure 5C ) but significantly reduced ETPs ( Figure 5D and 5E). Moreover, 7 days after sublethal irradiation, ADR-T SR-BI −/− mice exhibited smaller thymus weight ( Figure 5F ) and 48% lower thymic cellularity ( Figure 5G ) than ADR-T SR-BI +/+ mice, indicating that the thymic recovery was also delayed by adrenal SR-BI deficiency. The percentages of DN, double positive, CD4 SP, and CD8 SP thymocytes in ADR-T SR-BI −/− mice were also not significantly different from those in ADR-T SR-BI +/+ mice during thymic recovery ( Figure 5H ). Altogether, these data indicated that adrenal SR-BI deficiency is responsible for the impaired thymopoiesis in SR-BI −/− mice. Transplanting SR-BI +/+ adrenals to adrenalectomized SR-BI −/− mice failed to restore their adrenal function, 68 excluding the possibility of using the same method to see if restoration of adrenal function could rescue the defects in T-cell development in SR-BI −/− mice.
Discussion
In this study, we identify SR-BI as a novel regulator of thymopoiesis. Loss of SR-BI in mice impaired progenitor thymic homing, which further caused a reduction in thymus size, a decrease in T-cell production and delayed thymic recovery after irradiation. Interestingly, we found that adrenal SR-BI deficiency was the leading cause to the impaired T-cell development, whereas neither SR-BI deficiency-induced hypercholesterolemia nor hematopoietic SR-BI deficiency was responsible for the defects in T-cell development.
The major event of T-cell development affected by SR-BI deficiency was the BM progenitor thymic homing. When SR-BI was absent, lymphoid progenitor development was intact in the BM ( Figure VIII in the online-only Data Supplement), but fewer progenitors in the circulation entered the thymus to support thymopoiesis ( Figure 3F through 3I) . As a consequence, SR-BI-null mice showed significantly decreased ETPs ( Figure 3C through 3E) and thymic hypocellularity (Figure 1) , which was similar to other mouse strains whose progenitor thymic homing was blocked. 69, 70 In contrast, the percentages of thymocytes downstream of ETPs were not changed in SR-BI-null mice ( Figure 3J ), indicating the downstream T-cell development program inside the thymus was not blocked by SR-BI deficiency. During the thymic recovery after irradiation, thymocytes derived from circulating progenitors in SR-BI-null mice also displayed a comparable CD4/ CD8 profile with those in control mice ( Figure 4B and 4D) . Interestingly, we detected a decrease in the proliferation of DN2 cells ( Figure VIB in the online-only Data Supplement), the direct descendants of ETPs, in SR-BI −/− mice, which may result from the reduction in ETPs.
Importantly, the thymic output was reduced by SR-BI deficiency, causing narrowed peripheral naïve T-cell pool in young age mice (Figure 2 ). Of note, SR-BI-null mice at different ages displayed marked differences in T-cell homeostasis. SR-BI −/− mice >20 weeks displayed T-cell expansion in the periphery, which was mainly attributed to a significant increase in memory T cells. 48 On the contrary, 5-week mice did not show elevated memory T-cell numbers, but their naïve T cells were markedly decreased ( Figure 2E through 2H) . The change in T-cell homeostasis could be explained by that in young ages, the reduction in T-cell production, which reduced naïve T-cell number, was the major factor influencing the T-cell homeostasis in SR-BI −/− mice; although as these mice grew old, the SR-BI deficiency-induced dysfunctional HDL gradually started to affect T cells, causing the expansion of memory T cells. The impaired thymopoiesis may also contribute to the autoimmune problem of the aged SR-BI-null mice, 48 as a decrease in T-cell production had been shown to induce the self-reactive T-cell accumulation in the periphery 57 and cause autoimmune problems. 71 The impaired progenitor thymic homing and the decrease in ETPs led to compromised T-cell regeneration after irradiation in SR-BI −/− mice. Using the sublethal irradiation model, in which thymic recovery highly depended on intrathymic progenitors, we observed that SR-BI −/− mice displayed delayed thymic recovery ( Figure 4A ), demonstrating that the reduction in ETPs because of SR-BI deficiency contributed to the impaired T-cell regeneration. Using BMT models, we found that SR-BI-deficient recipients not only exhibited impaired regeneration of thymocytes and intrathymic progenitors ( Figure 4C through 4F) but also showed compromised repopulation of peripheral T cells (Figure 4G ), indicating that the impaired progenitor thymic homing also resulted in the impaired thymic recovery in SR-BI-null mice.
Although the defects in T-cell development in SR-BI-null mice were attributed to the nonhematopoietic SR-BI deficiency, they were not induced by SR-BI deficiency-induced hypercholesterolemia, as neither exaggerating nor normalizing hypercholesterolemia in SR-BI −/− mice impacted their thymic cellularity (Figures XII through XIV in the online-only Data Supplement). Formerly it was reported that increased cholesterol accumulation in thymocytes caused an increase in thymocyte proliferation. 72 Thymocytes from SR-BI-null mice did not show elevated cholesterol accumulation (data not shown) or accelerated proliferation ( Figure 4E and 4F) , indicating SR-BI did not play a role in regulating cholesterol levels of thymocytes.
Impaired T-cell development and narrow naïve T-cell pool could lead to an impaired T-cell function. Indeed, we did find both Six wks later, (A and B) thymus weight and thymic cellularity were analyzed, n=4-5 per group; (C and D) the thymic CD4/CD8 prolife and double negative (DN)1-4 profile were detected, n=4-5 per group; (E and F) the percentage and number of ETP were evaluated, n=4-5 per group. G through I, Six wks after adrenal transplantation, recipient mice were irradiated with a single dose of 450 rads from a cesium source. Seven days after irradiation, the thymus weight was analyzed (G), thymocyte numbers (H) and thymocyte CD4/CD8 profile (I) were analyzed. n=7-9 per group. *P<0.05, **P<0.01, and ***P<0.001. 4SP indicates CD4 single positive; 8SP, CD8 single positive; and DP, double positive.
Data Supplement) and activation ( Figure XVIIE and XVIIF in the online-only Data Supplement) in response to anti-CD3 stimulation. However, contradictory observations were made in vivo, as SR-BI −/− mice displayed T-cell hyperactivation and autoimmune problem. 37 We immunized SR-BI −/− and SR-BI +/+ mice with sheep red blood cells and found that SR-BI −/− had comparable follicular helper T-cells and germinal B-cell formation ( Figure XVIIG and XVIIH in the online-only Data Supplement). The controversial observations in vitro and in vivo might be explained by the fact that T cells were exposed to the SR-BI deficiency-caused dysfunctional HDL in vivo, which had been shown to increase T-cell activation and proliferation. 37 Given that the liver-expressed SR-BI and adrenalexpressed SR-BI play dual and potentially opposite roles in T-cell function, further studies involving liver-and adrenalspecific SR-BI knockout mice were warranted to accurately dissect how SR-BI in either site affects T-cell function in vivo.
Glucocorticoid has been shown to be a critical regulator of T-cell development. Overexpression of GR in thymocytes 73 results in a decrease in thymus size, whereas adrenalectomy increases thymus size. 74, 75 Moreover, glucocorticoid seems to modulate selection processes, as shown by that conditional knockout of GR in T-lineage cells causes a shift of the selection threshold, resulting in altered TCR repertoire and compromised T-cell functions. 76, 77 In this study, we found that mice lacking adrenal SR-BI had impaired T-cell development and ETP homing ( Figure 5 ), indicating that the absence of adrenal SR-BI was mainly responsible for the defects in T-cell development. Our data provide a new link between steroidogenesis in adrenal gland and T-cell development. Indeed, many laboratories, including ours, have shown that adrenal SR-BI plays a pivotal role in providing cholesterol for glucocorticoid synthesis in adrenal cells 67 and in mediating the production of stress levels of glucocorticoid in stressed conditions. 30, 31, 45, 69 Interestingly, although the earlier reports did not show a deficiency of SR-BI affects glucocorticoid levels at physiological conditions, when trained the mice for 10 days to exclude the effect of stress and then measured the corticosterone levels at different time, we found that SR-BI −/− mice lose glucocorticoid circadian (unpublished data). Whether this contributes to impaired T-cell development and thymic regeneration warrants further investigation.
Thymus underdoes atrophy with aging. Given the contribution of adrenal SR-BI to T-cell development, we analyzed the adrenal SR-BI expression and found that the adrenal SR-BI expression is moderately decreased in aged SR-BI +/+ mice, but the liver SR-BI is significantly increased in aged SR-BI +/+ mice ( Figure XVIII in the online-only Data Supplement). In this study, we found that mice deficient in SR-BI have thymus atrophy, it is likely that a decrease in adrenal SR-BI expression may contribute to thymus atrophy with aging.
Collectively, in this study, we identified a formerly unseen function of SR-BI in T-cell development. SR-BI deficiency in mice causes a reduction in thymic size, a decrease in T-cell production and delayed thymic recovery by impairing progenitor thymic homing, and adrenal SR-BI deficiency is responsible for the defects in T-cell development. As thymic involution increases the risks to infection and is extremely slow to recover, [78] [79] [80] our findings provided SR-BI as a novel potential target to enhance thymic regeneration and may lead effort to new strategies to improve immune functions of patients.
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